Select Medical Sees FY24 EPS $1.96-$2.20 Vs $2.03 Est.; Revenue $6.9B-$7.1B Vs $6.97B Est.
Select Medical Sees FY24 EPS $1.96-$2.20 Vs $2.03 Est.; Revenue $6.9B-$7.1B Vs $6.97B Est.
Business Outlook
商業展望
Select Medical is reaffirming its 2024 business outlook for revenue and adjusting its 2024 business outlook for Adjusted EBITDA and fully diluted earnings per share, which was provided most recently in its February 22, 2024, press release. Select Medical is also issuing its business outlook for adjusted earnings per share. Select Medical expects revenue to be in the range of $6.9 billion to $7.1 billion, Adjusted EBITDA to be in the range of $845 million to $885 million, fully diluted earnings per share to be in the range of $1.95 to $2.19 and adjusted earnings per share to be in the range of $1.96 to $2.20. Reconciliations of full year 2024 Adjusted EBITDA expectations to net income and adjusted earnings per share to fully diluted earnings per share are presented in table VIII of this release.
Select Medical重申了其2024年的業務收入展望，並調整了其2024年的業務展望，包括調整後的息稅折舊攤銷前利潤和全面攤薄後的每股收益，這些前景最近在2024年2月22日的新聞稿中公佈。Select Medical還發布了調整後每股收益的業務展望。Select Medical預計，收入將在69億美元至71億美元之間，調整後的息稅折舊攤銷前利潤將在8.45億美元至8.85億美元之間，全面攤薄後的每股收益將在1.95美元至2.19美元之間，調整後的每股收益將在1.96美元至2.20美元之間。本新聞稿的表八列出了2024年全年調整後息稅折舊攤銷前利潤預期與淨收益以及調整後每股收益與全面攤薄後的每股收益的對賬情況。
譯文內容由第三人軟體翻譯。